Sage Journals: Discover world-class research

Retricted access

Research article

First published 1996-06

Development of cladribine treatment in multiple sclerosis

JC Sipe, JS Romine, JA Koziol [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-10

Cladribine: An Investigational Immunomodulatory Agent for Multiple Sclerosis

Julie A Brousil, Russel J Roberts, Amanda L Schlein

Annals of Pharmacotherapy

Retricted access

Research article

First published 2018-10

Cladribine versus fingolimod,natalizumab and interferon β for multiple sclerosis

Tomas Kalincik, Vilija Jokubaitis, Tim Spelman [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2011-5

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

S Cook, P Vermersch, G Comi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2023-3

Cladribine and pregnancy in women with multiple sclerosis: The first cohort study

Karen Dost-Kovalsky, Sandra Thiel, Andrea I Ciplea [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2025

Cladribine monotherapy in a patient with coexisting Crohn’s disease and multiple sclerosis

Solène Dauby, Dominique Dive, Isabelle Hansen [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Identifying Cladribine prescription pattern in MS: an Italian multicentre study

Aurora Zanghì, Roberta Fantozzi, Matteo Foschi [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Case report

First published 2021-4

Cladribine transfer into human milk: A case report

Palika Datta, Andrea I Ciplea, Kathleen Rewers-Felkins [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2023-1

Prediction of relapse activity when switching to cladribine for multiple sclerosis

Michael Zhong, Anneke van der Walt, Mastura Monif [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019

Therapy with cladribine is efficient and safe in patients previously treated with natalizumab

Nora Möhn, Thomas Skripuletz, Kurt-Wolfram Sühs [...]

Therapeutic Advances in Neurological Disorders

Search results